Results 201 to 210 of about 33,145 (233)
Some of the next articles are maybe not open access.
Journal of Biomedical Nanotechnology
Oncolytic viruses have made tremendous advances in fundamental research and clinical trials in recent years as potential anti-cancer medications. Oncolytic viruses, which are either genetically modified or naturally occurring, can kill cancer cells without harming healthy cells.
Chen Wu +3 more
openaire +1 more source
Oncolytic viruses have made tremendous advances in fundamental research and clinical trials in recent years as potential anti-cancer medications. Oncolytic viruses, which are either genetically modified or naturally occurring, can kill cancer cells without harming healthy cells.
Chen Wu +3 more
openaire +1 more source
Oncolytic virus therapy for prostate cancer
International Journal of Urology, 2009AbstractThe use of replication‐competent viruses that can selectively replicate in and destroy neoplastic cells is an attractive strategy for treating cancer. Various oncolytic viruses have been taken to clinical trials since a recombinant virus was first applied to cancer patients a decade ago.
Hiroshi, Fukuhara +2 more
openaire +2 more sources
Spatial Oncolytic Virus Dynamics
2013Tumors are often characterized by intricate spatial structures. Therefore, understanding the principles of virus spread in spatially structured tumor cell populations is of fundamental importance. This chapter describes a two-dimensional spatial model where cells and viruses can place their offspring only into the direct vicinity. This describes a cell
Natalia L. Komarova, Dominik Wodarz
openaire +1 more source
Measles as a potential oncolytic virus
Reviews in Medical Virology, 2005The use of replicating viruses for cancer therapy is attracting increasing interest. Numerous viruses are now being considered as potential cancer therapeutics, including the vaccine strain of measles virus (MV). The attenuated strain of measles readily lyses transformed cells, whilst replication and lysis are limited in normal human cells.
openaire +2 more sources
Cancer gene and oncolytic virus therapy
Seminars in Oncology, 2001By far, cancer accounts for the majority of gene therapy trials that are being carried out worldwide. Seventy percent of the gene therapy protocols that have been reviewed by the National Institutes of Health Recombinant DNA Advisory Committee (NIH RAC) are for the treatment of cancer.
openaire +2 more sources
Recent advances in oncolytic virus design
Clinical and Translational Oncology, 2011The cytolytic properties of viruses can be used to treat cancer. Replication of certain viruses is favoured in cancer cells, whereas others can be modified to obtain tumour specificity. This approach has evolved to become a new discipline called virotherapy.
openaire +2 more sources
Advancing oncolytic virus therapy by understanding the biology
Nature Reviews Clinical Oncology, 2021Howard L Kaufman
exaly
Cervical cancer prevention and control in women living with human immunodeficiency virus
Ca-A Cancer Journal for Clinicians, 2021Philip E Castle, Vikrant V Sahasrabuddhe
exaly
Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma
New England Journal of Medicine, 2022Jaime Gállego Pérez-Larraya +2 more
exaly

